“…17 Therefore, the use of RNAi by a stable viral vector system, such as the adenovirus (Ad), is a possible strategy for stable gene knockdown. In fact, constitutive expression of short hairpin RNA by Ad vectors has been shown for several weeks, thereby consolidating this technology as an alternative to generating liver-specific knockout animals, 18 as development of potential agents to treat hepatitis B 9,19,20 or to generate antitumor therapies against antiapoptotic genes 18,21 or genes involved in the cell cycle. 22 The objective of this study was to achieve intratumoral local delivery of siRNA using LNPs or Ad vectors.…”